{"id":"W4411417568","doi":"10.1016/j.ard.2025.05.243","title":"OP0232 CANCER INCIDENCE AMONG RHEUMATOID ARTHRITIS PATIENTS TREATED WITH JAK-INHIBITORS COMPARED TO bDMARDs: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTERS (THE “JAK-POT” STUDY)","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Rheumatoid arthritis; Incidence (geometry); Tofacitinib; Internal medicine; Biologic Agents; Oncology; Arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001448613,0.0003218048,0.000507021,0.001858813,0.0003804204,0.0007104612,0.0006199675,0.0003576187,0.00237168],"category_scores_gemma":[0.003925675,0.0002358773,0.000811219,0.004308569,0.0002673525,0.000298737,0.0006661114,0.0004071287,0.000321714],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001424067,"about_ca_system_score_gemma":0.001162986,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.2120808,"about_ca_topic_score_gemma":0.2249856,"domain_scores_codex":[0.9984504,0.0004350815,0.0002082017,0.000405319,0.0003135449,0.0001875139],"domain_scores_gemma":[0.9966061,0.0006323077,0.001780483,0.0003113751,0.0004198722,0.0002498633],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004702839,0.00001810125,0.9970987,0.00004763425,0.00025493,0.00002329699,0.00004139329,0.00009111089,0.0000812692,0.00002273642,0.0006441427,0.001206508],"study_design_scores_gemma":[0.00006480558,0.00009470883,0.9987853,0.00001549789,0.0001115933,0.00006955044,0.00007342517,0.0002181547,0.00003834689,0.00001114901,0.0005124806,0.000004875344],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.96918,0.000896291,0.000239642,0.0000604614,0.000006675858,0.00005258105,0.02867424,0.00001746285,0.0008726093],"genre_scores_gemma":[0.9844809,0.0003486558,0.0001703129,0.00003678518,0.00001215527,0.00006647951,0.01451753,0.000008116599,0.0003590407],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2120808,"threshold_uncertainty_score":0.4216927,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03713003997147955,"score_gpt":0.3569601483590484,"score_spread":0.3198301083875688,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}